Attachbio Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Attachbio General Information
Description
Developer of a microfluidic platform designed to identify disease-relevant T cells. The company's technology utilizes avidity-based isolation and fluidic shear stress to separate antigen-specific T cells without prior antigen identification, providing the healthcare industry with a rapid and HLA-agnostic method to accelerate cancer TCR discovery and refine precision immunotherapies.
Contact Information
Website
www.attachbio.comCorporate Office
- Houston, TX
- United States
Corporate Office
- Houston, TX
- United States
Attachbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Nov-2026 | Completed | Generating Revenue |
Attachbio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Attachbio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Medical Center | Venture Capital | Minority |
Attachbio FAQs
-
When was Attachbio founded?
Attachbio was founded in 2025.
-
Where is Attachbio headquartered?
Attachbio is headquartered in Houston, TX.
-
What industry is Attachbio in?
Attachbio’s primary industry is Biotechnology.
-
Is Attachbio a private or public company?
Attachbio is a Private company.
-
What is Attachbio’s current revenue?
The current revenue for Attachbio is .
-
Who are Attachbio’s investors?
Texas Medical Center has invested in Attachbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
